Additional evidence supporting this idea is that inhibition of PI3K/AKT and MEK/ERK pathways both enhance the activation of FOXO transcription factors in pancreatic cancer cells (Roy et al., 2010). This evidence concerns the gene AKT1 and familial pancreatic carcinoma.